Synthace
PrivateLast Round
Series C
Nov 16, 2021
Est. Valuation
$71.3M
Total Funding Raised
$76.37M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Synthace is a biotechnology company that offers a laboratory automation platform aimed at transforming biological experimentation by streamlining data management and facilitating the planning and execution of complex experiments.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Workflow Automation, Low-Code/No-Code, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synthace Comparables
Compare Synthace with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Labforward | 82% | |
| TetraScience | 80% | |
| Artificial, Inc. | 80% | |
Synthace Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 16, 2021 | ||||
| Series B | Dec 12, 2018 | ||||
| Series A | Sep 19, 2017 | ||||
| Seed | Feb 11, 2015 | ||||
| Seed | Sep 23, 2014 | ||||
Grant | Mar 7, 2013 |
Key People
Founding team and executive leadership
Synthace Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Series A |
| Horizons Ventures | Series B, Series C |
| Voyagers.io | Series C |
| Biotechnology and Biological Sciences Research Council (BBSRC) | Grant |
| Innovate UK | Grant |
| UK Innovation & Science Seed Fund | Seed |
| Bioeconomy Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 32% MoM.
- Apr 1, 2026
Added Charles River Laboratories International as a customer.
Synthace Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synthace's valuation, stock price, and market status.